Switch to:

Regeneron Pharmaceuticals Days Sales Outstanding

: 111.27 (As of Jun. 2020)
View and export this data going back to 1991. Start your Free Trial

Regeneron Pharmaceuticals's Accounts Receivable for the three months ended in Jun. 2020 was $2,380 Mil. Regeneron Pharmaceuticals's Revenue for the three months ended in Jun. 2020 was $1,952 Mil. Hence, Regeneron Pharmaceuticals's days sales outstanding for the three months ended in Jun. 2020 was 111.27.

NAS:REGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 65.13   Med: 123.38   Max: 183.53
Current: 108.62

65.13
183.53

During the past 13 years, Regeneron Pharmaceuticals's highest Days Sales Outstanding was 183.53. The lowest was 65.13. And the median was 123.38.

NAS:REGN's Days Sales Outstanding is ranked lower than
72% of the 733 Companies
in the Biotechnology industry.

( Industry Median: 72.50 vs. NAS:REGN: 108.62 )

Regeneron Pharmaceuticals's days sales outstanding declined from Jun. 2019 (142.03) to Jun. 2020 (111.27).


Regeneron Pharmaceuticals Days Sales Outstanding Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Regeneron Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.55 121.03 122.72 122.01 124.04

Regeneron Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Days Sales Outstanding Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 142.03 118.49 112.39 126.35 111.27

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Regeneron Pharmaceuticals Days Sales Outstanding Distribution

* The bar in red indicates where Regeneron Pharmaceuticals's Days Sales Outstanding falls into.



Regeneron Pharmaceuticals Days Sales Outstanding Calculation

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Regeneron Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=2672.2/7863.4*365
=124.04

Regeneron Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Jun. 2020 is calculated as:

Days Sales Outstanding=Accounts Receivable/Revenue*Days in Period
=2380.2/1952*365 / 4
=111.27

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Regeneron Pharmaceuticals  (NAS:REGN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Regeneron Pharmaceuticals Days Sales Outstanding Related Terms


Regeneron Pharmaceuticals Days Sales Outstanding Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)